Search research articles
Contact Us
Filters
Showing results (331-340 of 362) with videos related to
Page
of 37
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 16, 2009
Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and clostridium difficile infection
Shomron Ben-Horin, Maya Margalit, Peter Bossuyt, et al.
Journal of Crohn'S & Colitis
|
April 10, 2021
Dose optimisation for Loss of Response to Vedolizumab- Pharmacokinetics and Immune Mechanisms
Bella Ungar, Karin Malickova, Jurij Hanžel, et al.
Gastroenterology
|
March 9, 2026
Perturbations of Diet and Gut Signatures Persist During Remission in Crohn's Disease Despite Effective Immune Suppression
Tzipi Braun, Nina Levhar, Gilat Efroni, et al.
The Lancet. Gastroenterology & Hepatology
|
February 16, 2019
Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and Development
James A King, Fox E Underwood, Nicola Panaccione, et al.
United European Gastroenterology Journal
|
October 5, 2024
Defining mucosal healing in randomized controlled trials of inflammatory bowel disease: A systematic review and future perspective
Tommaso Lorenzo Parigi, Virginia Solitano, Alessandro Armuzzi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 7, 2020
Early Indolent Course of Crohn's Disease in Newly Diagnosed Patients Is Not Rare and Possibly Predictable
Henit Yanai, Idan Goren, Lihi Godny, et al.
Alimentary Pharmacology & Therapeutics
|
September 19, 2018
The role of multimodal treatment in Crohn's disease patients with perianal fistula: a multicentre retrospective cohort study
Shaji Sebastian, Christopher Black, Daniela Pugliese, et al.
The Lancet. Gastroenterology & Hepatology
|
January 14, 2023
Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial
Edouard Louis, Matthieu Resche-Rigon, David Laharie, et al.
Journal of Crohn'S & Colitis
|
December 3, 2010
Prevalence and clinical impact of endoscopic pseudomembranes in patients with inflammatory bowel disease and Clostridium difficile infection
Shomron Ben-Horin, Maya Margalit, Peter Bossuyt, et al.
European Journal of Gastroenterology & Hepatology
|
February 20, 2016
European experience with methotrexate treatment in Crohn's disease: a multicenter retrospective analysis
Uri Kopylov, Konstantinos H Katsanos, Christien Janneke van der Woude, et al.
Page
of 37
Search research articles
Search
Showing results (331-340 of 362) with videos related to
Sort By:
Page
of 37
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 16, 2009
Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and clostridium difficile infection
Shomron Ben-Horin, Maya Margalit, Peter Bossuyt, et al.
Journal of Crohn'S & Colitis
|
April 10, 2021
Dose optimisation for Loss of Response to Vedolizumab- Pharmacokinetics and Immune Mechanisms
Bella Ungar, Karin Malickova, Jurij Hanžel, et al.
Gastroenterology
|
March 9, 2026
Perturbations of Diet and Gut Signatures Persist During Remission in Crohn's Disease Despite Effective Immune Suppression
Tzipi Braun, Nina Levhar, Gilat Efroni, et al.
The Lancet. Gastroenterology & Hepatology
|
February 16, 2019
Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and Development
James A King, Fox E Underwood, Nicola Panaccione, et al.
United European Gastroenterology Journal
|
October 5, 2024
Defining mucosal healing in randomized controlled trials of inflammatory bowel disease: A systematic review and future perspective
Tommaso Lorenzo Parigi, Virginia Solitano, Alessandro Armuzzi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 7, 2020
Early Indolent Course of Crohn's Disease in Newly Diagnosed Patients Is Not Rare and Possibly Predictable
Henit Yanai, Idan Goren, Lihi Godny, et al.
Alimentary Pharmacology & Therapeutics
|
September 19, 2018
The role of multimodal treatment in Crohn's disease patients with perianal fistula: a multicentre retrospective cohort study
Shaji Sebastian, Christopher Black, Daniela Pugliese, et al.
The Lancet. Gastroenterology & Hepatology
|
January 14, 2023
Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial
Edouard Louis, Matthieu Resche-Rigon, David Laharie, et al.
Journal of Crohn'S & Colitis
|
December 3, 2010
Prevalence and clinical impact of endoscopic pseudomembranes in patients with inflammatory bowel disease and Clostridium difficile infection
Shomron Ben-Horin, Maya Margalit, Peter Bossuyt, et al.
European Journal of Gastroenterology & Hepatology
|
February 20, 2016
European experience with methotrexate treatment in Crohn's disease: a multicenter retrospective analysis
Uri Kopylov, Konstantinos H Katsanos, Christien Janneke van der Woude, et al.
Page
of 37